The Detection of Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus
NCT06749535 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2024-12-27
Summary
"Background: Chronic obstructive pulmonary disease (COPD) is an ongoing lung condition caused by damage to the lungs. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. Diabetes can worsen the progression and prognosis of COPD.
Conditions
Interventions
- RADIATION
-
group 1
The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD.
Sponsors & Collaborators
-
Superior University
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-28
- Primary Completion
- 2024-08-01
- Completion
- 2025-03-02
Countries
- Pakistan
Study Locations
More Related Trials
-
Diaphragmatic Function as a Biomarker
NCT05903001 ·Status: RECRUITING
-
Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease
NCT05214508 ·Status: COMPLETED ·Phase: NA
-
Investigation of Impairments in Body Functions and Structures, Activities and Participation Restrictions in COPD
NCT05632120 ·Status: ENROLLING_BY_INVITATION
-
Recognition of Early Pulmonary Structural Changes by Using Real-time High Fidelity Expiratory CO2 Analysis
NCT05092035 ·Status: COMPLETED ·Phase: NA
-
The Lung Microbiome and Endobronchial Valve Treatment
NCT04932811 ·Status: UNKNOWN
-
Comparison of Water Sorption Capacity and the Composition of Bronchial Fluids of Healthy Persons and Patients With Chronic Obstructive Bronchitis (COPD)
NCT04703023 ·Status: COMPLETED
-
Interstitial Lung Disease Questionnaire
NCT01711151 ·Status: UNKNOWN
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Refractory Breathlessness in COPD
NCT07160322 ·Status: RECRUITING
-
Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD
NCT03287921 ·Status: COMPLETED
-
Biomarkers in Chronic Obstructive Pulmonary Disease (COPD)
NCT01145300 ·Status: COMPLETED
-
Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease
NCT02826265 ·Status: UNKNOWN
-
Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases
NCT03400839 ·Status: UNKNOWN
-
Demonstration of Broncholytic Effects in Subjects With Obstructive Airway Diseases by Low Frequency Ultrasound
NCT01080924 ·Status: COMPLETED ·Phase: NA
-
The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data
NCT04183530 ·Status: UNKNOWN
-
Change in Airway Peripheral Tone in COPD
NCT04166812 ·Status: UNKNOWN
-
Prediction of COPD Severity Using Electrical Impedance Tomography
NCT06359145 ·Status: RECRUITING
-
Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
NCT05310669 ·Status: RECRUITING
-
Analysis of Exhaled Breath From Patients With Lung-/Airway Diseases (BigExBrESs)
NCT05458934 ·Status: RECRUITING
-
Multiple Breath Washout as a Method for Diagnosing Lung Diseases
NCT06179342 ·Status: COMPLETED
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED
-
Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis
NCT01410422 ·Status: UNKNOWN
-
Small Bioactive Molecules in Early COPD Diseases
NCT04950023 ·Status: UNKNOWN
-
Biomarkers of Chronic Obstructive Pulmonary Disease
NCT04963023 ·Status: COMPLETED
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA